In the last trading session, 1.11 million shares of the Microbot Medical Inc (NASDAQ:MBOT) were traded, and its beta was 1.61. Most recently the company’s share price was $1.36, and it changed around -$0.05 or -3.55% from the last close, which brings the market valuation of the company to $47.25M. MBOT currently trades at a discount to its 52-week high of $3.38, offering almost -148.53% off that amount. The share price’s 52-week low was $0.82, which indicates that the current value has risen by an impressive 39.71% since then.

Microbot Medical Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended MBOT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Microbot Medical Inc is expected to report earnings per share of -0.18 for the current quarter.

Microbot Medical Inc (NASDAQ:MBOT) trade information

Instantly MBOT has showed a red trend with a performance of -3.55% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.6700 on recent trading dayincreased the stock’s daily price by 18.56%. The company’s shares are currently up 21.43% year-to-date, but still down -12.82% over the last five days. On the other hand, Microbot Medical Inc (NASDAQ:MBOT) is -26.49% down in the 30-day period.

Forecasts for the next quarter put sales growth at 0.00%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 15.28%.

MBOT Dividends

Microbot Medical Inc’s next quarterly earnings report is expected to be released in April.

BLACKROCK INC., with 0.9773% or 0.14 million shares worth $0.14 million as of 2024-06-30, holds the second largest percentage of outstanding shares.